Key facts
- Mel-Frontier’s last known valuation is $6.3M (Oct 2020).
- It has raised $3.0M; the latest was Later Stage VC ($1.6M) in Oct 2025.
- Notable investors include SRD Holdings (Japan).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Mel-Frontier
- ·The full record, as it builds
Funding rounds
No funding rounds for Mel-Frontier are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mel-Frontier
Developer of bioabsorbable medical devices designed to help in medical treatments. The company provides a bone fixing screw in order to fix the bones of the limbs that are damaged due to fractures, which will be gradually decomposed and discharged, enabling healthcare professionals to improve the situation in growing pediatric patients who need to be re-hospitalized and operated on for removal.
- Sector
- Healthcare
- HQ
- Bunkyo-ku, Japan
- Founded
- 2016
- Website
- mel-frontier.jp/
- Ownership
- Privately Held (backing)
Mel-Frontier doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mel-Frontier shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mel-Frontier in its N-PORT filings yet. We sweep new filings monthly.